Literature DB >> 14699448

The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain.

N J Bray1, P R Buckland, H Hall, M J Owen, M C O'Donovan.   

Abstract

The serotonin-2A (HTR2A) receptor is a molecule of particular interest in biological psychiatry, as it is an important target for psychotropic drugs, and altered HTR2A expression has been found in several neuropsychiatric conditions, including depression and schizophrenia. Genetic association has been reported between a synonymous 102T/C polymorphism in the gene encoding HTR2A and a number of clinical phenotypes, including schizophrenia, clozapine response, psychotic symptoms in Alzheimer's disease and certain features of depression. Given that there are no known effects of the 102T/C polymorphism on the structure of the receptor, attention has switched to the possibility that the observations of both altered expression and genetic association point to functional sequence variants that alter expression of the HTR2A gene. Moreover, data have been presented recently suggesting that mRNAs containing the 102T- and C-alleles are differentially expressed. This suggests a direct effect of the variant itself on mRNA levels, or the influence of a distinct regulatory variant, such as the -1438A/G promoter polymorphism, with which it is in perfect linkage disequilibrium. The present study tested this hypothesis by employing a highly accurate quantitative allele- specific primer extension assay to measure the relative expression of brain mRNAs carrying each allele in 23 individuals heterozygous for the 102T/C polymorphism. Comparison between allele ratios derived from genomic DNA and mRNA from several cortical regions revealed that the 102C- and T-alleles are expressed identically. Furthermore, the absence of any interindividual variability in relative mRNA allele ratio suggests that the HTR2A locus is unlikely to contain common polymorphisms or epigenetic modification that alter HTR2A mRNA levels in adult brain, and essentially exclude such phenomena as a potential explanation for the altered expression and genetic associations that have been reported to date.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14699448     DOI: 10.1038/sj.mp.4001366

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  19 in total

1.  Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues.

Authors:  Andrew D Johnson; Ying Zhang; Audrey C Papp; Julia K Pinsonneault; Jeong-Eun Lim; David Saffen; Zunyan Dai; Danxin Wang; Wolfgang Sadée
Journal:  Pharmacogenet Genomics       Date:  2008-09       Impact factor: 2.089

2.  Family-based clinical associations and functional characterization of the serotonin 2A receptor gene (HTR2A) in autism spectrum disorder.

Authors:  Ryan M Smith; Wesley Banks; Emily Hansen; Wolfgang Sadee; Gail E Herman
Journal:  Autism Res       Date:  2014-04-17       Impact factor: 5.216

3.  Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.

Authors:  Francis J McMahon; Silvia Buervenich; Dennis Charney; Robert Lipsky; A John Rush; Alexander F Wilson; Alexa J M Sorant; George J Papanicolaou; Gonzalo Laje; Maurizio Fava; Madhukar H Trivedi; Stephen R Wisniewski; Husseini Manji
Journal:  Am J Hum Genet       Date:  2006-03-20       Impact factor: 11.025

4.  Stress exposure and psychopathology alter methylation of the serotonin receptor 2A (HTR2A) gene in preschoolers.

Authors:  Stephanie H Parade; Andrew M Novick; Justin Parent; Ronald Seifer; Samantha J Klaver; Carmen J Marsit; Asi Polly Gobin; Bao-Zhu Yang; Audrey R Tyrka
Journal:  Dev Psychopathol       Date:  2017-12

5.  Haplotype structure and divergence at human and chimpanzee serotonin transporter and receptor genes: implications for behavioral disorder association analyses.

Authors:  Katrina G Claw; Raul Y Tito; Anne C Stone; Brian C Verrelli
Journal:  Mol Biol Evol       Date:  2010-01-29       Impact factor: 16.240

6.  Pilot study on HTR2A promoter polymorphism, -1438G/A (rs6311) and a nearby copy number variation showed association with onset and severity in early onset obsessive-compulsive disorder.

Authors:  Susanne Walitza; Daniel Sabanés Bové; Marcel Romanos; Tobias Renner; Leonhard Held; Michael Simons; Christoph Wewetzer; Christian Fleischhaker; Helmut Remschmidt; Andreas Warnke; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2011-08-28       Impact factor: 3.575

7.  Gender Interacts with Opioid Receptor Polymorphism A118G and Serotonin Receptor Polymorphism -1438 A/G on Speed-Dating Success.

Authors:  Karen Wu; Chuansheng Chen; Robert K Moyzis; Ellen Greenberger; Zhaoxia Yu
Journal:  Hum Nat       Date:  2016-09

8.  Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex.

Authors:  Ryan M Smith; Audrey C Papp; Amy Webb; Cara L Ruble; Leanne M Munsie; Laura K Nisenbaum; Joel E Kleinman; Barbara K Lipska; Wolfgang Sadee
Journal:  Biol Psychiatry       Date:  2012-11-13       Impact factor: 13.382

Review 9.  The role of the serotonergic system at the interface of aggression and suicide.

Authors:  M Bortolato; N Pivac; D Muck Seler; M Nikolac Perkovic; M Pessia; G Di Giovanni
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

Review 10.  Epigenetic mechanisms in schizophrenia.

Authors:  Tania L Roth; Farah D Lubin; Monsheel Sodhi; Joel E Kleinman
Journal:  Biochim Biophys Acta       Date:  2009-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.